Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how competitive Abecma will continue to be in the multiple myeloma space given an ...

The crypto world saw major developments this week, including a trader losing $5 million and the Ripple-SEC lawsuit nearing ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Learn more about whether BrightSpring Health Services, Inc. or Select Medical Holdings Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

The company is not selling any shares of its common stock under this prospectus and will not receive any of the proceeds from the sale of the ...

Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, ...

Alzamend Neuro , Inc. (NASDAQ:ALZN), a biopharmaceutical company specializing ... Stock for an equal number of Series C Convertible Preferred Stock, along with the sale of up to 500 shares of Series C ...